For example, the application of VB124, a potent MCT4 inhibitor, has been shown to suppress HCC tumor growth in immunocompetent mouse models by enhancing CD8+ T cell infiltration and cytotoxicity. Here, CD8A is linked to hepatocellular carcinoma.